Revolutionizing Patient Referrals with AI: Our Partnership with Tennr
ICONIQ proudly partners with Tennr to streamline patient referral processes and deliver faster, transparent care.

Tennr co-founders Trey Holterman, Tyler Johnson, and Diego Baugh

Revolutionizing Patient Referrals with AI: Our Partnership with Tennr

ICONIQ proudly partners with Tennr to streamline patient referral processes and deliver faster, transparent care.

Tennr co-founders Trey Holterman, Tyler Johnson, and Diego Baugh

Copy page URL to clipboard

Share on X

Share on LinkedIn

https://www.iconiqcapital.com/growth/insights/revolutionizing-patient-referrals-with-ai-our-partnership-with-tennr

Stay Ahead with ICONIQ

For millions of patients and providers, healthcare referrals are a frustrating constant: slow, hard to track, and tangled in outdated systems. Every year more than one-third of Americans are referred to specialists, yet the process remains stuck in a patchwork of faxes, emails and portals. The impact is predictable: delayed care, overwhelmed staff and missed revenue.

Tennr is working to rewrite this narrative with a category-defining approach to referral automation. We, at ICONIQ, are thrilled to partner with Tennr in its Series C funding round, as they strive to bring precision, transparency and efficiency to referral management. The platform, powered by a proprietary AI model, does more than streamline operations, it unlocks time, visibility, and care for patients and providers alike.

At the core of Tennr is RaeLM, the first self-learning vision-language model trained on millions of healthcare documents. Tennr reads, extracts, and acts on referral data in various formats with speed and accuracy.

What struck us most in our early conversations with the Tennr team was not just the strength of their technical foundation, but the depth of their personal experiences that shaped Tennr’s mission. Co-founders Trey Holterman, Diego Baugh, and Tyler Johnson launched Tennr out of the Stanford AI Lab with a clear goal: to ensure no patient falls through the cracks. Trey spent years watching his mom wrestle with broken referral workflows in family medicine. Diego experienced the chaos firsthand as a patient. And together, with Tyler’s expert engineering leadership, they set out to bring world-class technical depth to a corner of healthcare that had long been overlooked and underserved.

We spoke with several Tennr customers, ranging from specialist physician groups to DME suppliers, imaging centers and beyond, who shared their love for Tennr. Customers commented that it increases throughput, reduces denials, saves time and drives measurable ROI. At NEB Medical, intake processing time dropped by over 60 percent, enabling teams to triple daily capacity. Eastern MedTech scaled document handling eightfold without adding headcount. 

Tennr is looking to make a broader impact that goes well beyond operations. At the heart of Tennr’s mission is bringing real-time visibility to the patient journey.  

Take, for example, a patient referred by their primary care doctor for infusion therapy. If that referral is delayed or lost in the shuffle due to administrative gaps, the consequences can be serious: care is postponed, conditions worsen, and patients are left to navigate the system on their own or fall out of it entirely.

Tennr’s newest launch, the Tennr Network, is designed to change this by transforming referrals into a transparent, collaborative journey. By connecting referring providers, receiving providers, and patients, Tennr gives all parties shared, real-time visibility into referral status. The referral is no longer a black hole. It’s trackable, responsive, and easy to follow.  

We believe the Tennr team has demonstrated a deep understanding of healthcare’s complexities and an impressive ability to build robust technology tailored precisely to those pain points. As Tennr continues to work on redefining patient processes for referral-based care, we look forward to supporting their mission to ensure no patient is left waiting unnecessarily and no provider is burdened by avoidable administrative hurdles.

Congratulations to Trey, Diego, Tyler, and the entire team on this next chapter. We are excited for what’s ahead in your journey and grateful to be a part of it!

Welcome, Tennr to the ICONIQ family—here’s to bringing a more transparent and efficient healthcare experience in a digital world.

The ICONIQ Venture and Growth website does not present information relating to ICONIQ, its investment funds, or its advisory business and should not be consulted for any advisory purposes. The ICONIQ Venture and Growth content is intended for the use of company founders and executives.

Notes

Disclaimer

The views expressed in this presentation are those of ICONIQ Venture & Growth ("ICONIQ" or the "firm"), are the result of proprietary research, may be subjective, and may not be relied upon in making an investment decision. 

 This presentation is for general information purposes only and does not constitute investment advice.  This presentation must not be relied upon in connection with any investment decision.  The information in this presentation is not intended to and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services.  Nothing in this presentation is or should be construed as an offer, invitation or solicitation to engage in any investment activity or transaction, including an offer to sell or a solicitation of an offer to buy any securities which should only be made pursuant to definitive offering documents and subscription agreements, including without limitation, any investment fund or investment product referenced herein.  

Any reproduction or distribution of this presentation in whole or in part, or the disclosure of any of its contents, without the prior consent of ICONIQ, is strictly unauthorized.  

This presentation may contain forward-looking statements based on current plans, estimates and projections.  The recipient of this presentation ("you") are cautioned that a number of important factors could cause actual results or outcomes to differ materially from those expressed in, or implied by, the forward-looking statements.  The numbers, figures and case studies included in this presentation have been included for purposes of illustration only, and no assurance can be given that the actual results of ICONIQ or any of its partners and affiliates will correspond with the results contemplated in the presentation.  No information is contained herein with respect to conflicts of interest, which may be significant.  The portfolio companies and other parties mentioned herein may reflect a selective list of the prior investments made by ICONIQ.  

Certain of the economic and market information contained herein may have been obtained from published sources and/or prepared by other parties.  While such sources are believed to be reliable, none of ICONIQ or any of its affiliates and partners, employees and representatives assume any responsibility for the accuracy of such information.  

All of the information in the presentation is presented as of the date made available to you (except as otherwise specified), and is subject to change without notice, and may not be current or may have changed (possibly materially) between the date made available to you and the date actually received or reviewed by you.  ICONIQ assumes no obligation to update or otherwise revise any information, projections, forecasts or estimates contained in the presentation, including any revisions to reflect changes in economic or market conditions or other circumstances arising after the date the items were made available to you or to reflect the occurrence of unanticipated events.  

For avoidance of doubt, ICONIQ is not acting as an adviser or fiduciary in any respect in connection with providing this presentation and no relationship shall arise between you and ICONIQ as a result of this presentation being made available to you.  

ICONIQ is a diversified financial services firm and has direct client relationships with persons that may become limited partners of ICONIQ funds.  Notwithstanding that a person may be referred to herein as a "client" of the firm, no limited partner of any fund will, in its capacity as such, be a client of ICONIQ.  There can be no assurance that the investments made by any ICONIQ fund will be profitable or will equal the performance of prior investments made by persons described in this presentation. 

Any information in this presentation is directed at, and intended for, only persons who are experienced institutional or professional investors (“professional investors”) as defined by applicable law and regulation.  Any person that is not a professional investor is not an intended recipient of this presentation and the matters discussed herein.

ICONIQ is a trading name of certain ICONIQ Partners (UK) LLP. ICONIQ Partners (UK) LLP (Registration Number: 973080) is an appointed representative of Kroll Securities Ltd. (Registration Number: 466588) which is authorised and regulated by the Financial Conduct Authority. ICONIQ Partners (UK) LLP is a limited liability partnership whose members are ICONIQ Capital (UK) Ltd, Seth Pierrepont and Lou Thorne, and it is registered in England and Wales and has its registered office at 27 Soho Square, London W1D 3QR. ICONIQ Partners (UK) LLP acts as an adviser to ICONIQ Capital LLC

Unless otherwise indicated, the views expressed in this presentation are those of ICONIQ Venture and Growth (“ICONIQ" or the “Firm"), are the result of proprietary research, may be subjective, and may not be relied upon in making an investment decision. Information used in this presentation was obtained from numerous sources. Certain of these companies are portfolio companies of ICONIQ Venture and Growth. ICONIQ Venture and Growth does not make any representations or warranties as to the accuracy of the information obtained from these sources.

This presentation is for general information purposes only and does not constitute investment advice. This presentation must not be relied upon in connection with any investment decision. The information in this presentation is not intended to and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services. Nothing in this presentation is or should be construed as an offer, invitation or solicitation to engage in any investment activity or transaction, including an offer to sell or a solicitation of an offer to buy any securities which should only be made pursuant to definitive offering documents and subscription agreements, including without limitation, any investment fund or investment product referenced herein.

Any reproduction or distribution of this presentation in whole or in part, or the disclosure of any of its contents, without the prior consent of ICONIQ, is strictly unauthorized.

This presentation may contain forward-looking statements based on current plans, estimates and projections. The recipient of this presentation ("you") are cautioned that a number of important factors could cause actual results or outcomes to differ materially from those expressed in, or implied by, the forward-looking statements. The numbers, figures and case studies included in this presentation have been included for purposes of illustration only, and no assurance can be given that the actual results of ICONIQ or any of its partners and affiliates will correspond with the results contemplated in the presentation. No information is contained herein with respect to conflicts of interest, which may be significant. The portfolio companies and other parties mentioned herein may reflect a selective list of the prior investments made by ICONIQ.

Certain of the economic and market information contained herein may have been obtained from published sources and/or prepared by other parties. While such sources are believed to be reliable, none of ICONIQ or any of its affiliates and partners, employees and representatives assume any responsibility for the accuracy of such information.

All of the information in the presentation is presented as of the date made available to you (except as otherwise specified), and is subject to change without notice, and may not be current or may have changed (possibly materially) between the date made available to you and the date actually received or reviewed by you. ICONIQ assumes no obligation to update or otherwise revise any information, projections, forecasts or estimates contained in the presentation, including any revisions to reflect changes in economic or market conditions or other circumstances arising after the date the items were made available to you or to reflect the occurrence of unanticipated events. Numbers or amounts herein may increase or decrease as a result of currency fluctuations.

For avoidance of doubt, ICONIQ is not acting as an adviser or fiduciary in any respect in connection with providing this presentation and no relationship shall arise between you and ICONIQ as a result of this presentation being made available to you.

ICONIQ is a diversified financial services firm and has direct client relationships with persons that may become limited partners of ICONIQ funds. Notwithstanding that a person may be referred to herein as a "client" of the firm, no limited partner of any fund will, in its capacity as such, be a client of ICONIQ. There can be no assurance that the investments made by any ICONIQ fund will be profitable or will equal the performance of prior investments made by persons described in this presentation.

Any information in this presentation is directed at, and intended for, only persons who are experienced institutional or professional investors (“professional investors”) as defined by applicable law and regulation. Any person that is not a professional investor is not an intended recipient of this presentation and the matters discussed herein.

ICONIQ is a trading name of ICONIQ Partners (UK) LLP. ICONIQ Partners (UK) LLP (Registration Number: 973080) is an appointed representative of Kroll Securities Ltd. (Registration Number: 466588) which is authorised and regulated by the Financial Conduct Authority. ICONIQ Partners (UK) LLP is a limited liability partnership whose members are ICONIQ Capital (UK) Ltd, Seth Pierrepont and Lou Thorne, and it is registered in England and Wales and has its registered office at 27 Soho Square, London W1D 3QR. ICONIQ Partners (UK) LLP acts as an adviser to ICONIQ Capital LLC